Global Needle-Free Diabetes Care Market, By Devices Types (Treatment Devices, Diagnostic Devices), Treatment (Oral Insulin, Inhaled Insulin, Insulin Patch, Others), Application (Insulin Delivery, Other), End Users (Diagnostic Centers, Hospitals & Clinics, Other), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Needle-Free Diabetes Care Market
The needle-free diabetes care market is expected to witness market growth at a rate of 6.99% in the forecast period of 2021 to 2028 and is expected to reach USD 21,188.67 million by 2028. Data Bridge Market Research report on needle-free diabetes care market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rising prevalence of diabetes is escalating the growth of needle-free diabetes care market.
Insulin therapy is the prominent treatment for the diabetes if the patient doesn’t respond to the oral hypoglycemic agents for type 2 diabetes. The therapy is generally administered via submucosal route by using insulin injections for both type 1 and type 2-diabetes. Blood pricking is the usual procedure to analyze the blood glucose levels in the patient’s body during the diagnosis which might cause the needle-stick injuries for healthcare professionals leading to various infections and pain. Non-invasive needle-free diabetes products are thus, being deployed by individuals.
The emergence of transdermal patches that read blood sugar level through the skin without drawing the blood acts as one of the major factors driving the growth of needle-free diabetes care market. The increase in the adoption of unhealthy lifestyle such as consumption of junk food among population across the globe and rise in the number of obese people accelerate the needle-free diabetes care market growth. The growth in awareness regarding the disease and the treatments and technological advancements to enhance the treatment facilities further influence the needle-free diabetes care market. Additionally, growing geriatric population, increasing disease incidence, changing lifestyles and surge in healthcare spending positively affect the needle-free diabetes care market. Furthermore, rise in diabetes-related health expenditure in emerging economies extends profitable opportunities to the needle-free diabetes care market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the facility and concerns regarding and technical errors are the factors expected to obstruct the needle-free diabetes care market growth. Lack of awareness among people is projected to challenge the needle-free diabetes care market in the forecast period of 2021-2028.
This needle-free diabetes care market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on needle-free diabetes care market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Needle-Free Diabetes Care Market Scope and Market Size
The needle-free diabetes care market is segmented on the basis of devices types, treatment, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of devices type, the needle-free diabetes care market is segmented into treatment devices and diagnostic devices.
- On the basis of treatment, the needle-free diabetes care market is segmented into oral insulin, inhaled insulin, insulin patch and others.
- On the basis of application, the needle-free diabetes care market is segmented into insulin delivery and other.
- On the basis of end users, the needle-free diabetes care market is segmented into diagnostic centers, hospitals & clinics and other.
Global Needle-Free Diabetes Care Market Country Level Analysis
The needle-free diabetes care market is analyzed and market size insights and trends are provided by country, devices types, treatment, application and end users as referenced above.
The countries covered in the global needle-free diabetes care market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the needle-free diabetes care market because of the large diabetic population, changing lifestyle, increasing healthcare expenditure and rise in the number of obese people. Asia-Pacific is expected witness the fastest growth during the forecast period of 2021 to 2028 because of the presence of large diabetic population in the region.
The country section of the needle-free diabetes care market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The needle-free diabetes care market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for needle-free diabetes care market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the needle-free diabetes care market. The data is available for historic period 2011-2019.
Competitive Landscape and Needle-Free Diabetes Care Market Share Analysis
The needle-free diabetes care market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to needle-free diabetes care market.
The major players covered in the needle-free diabetes care market report are 3M, Bioject Medical Technologies Inc., Valeritas, Inc., Antares Pharma, Endo International plc, InsuJet, PharmaJet, PenJet, INJEX, Technologies Médicales Internationales (MIT Canada) Inc., Needle Free Injection System, Echo Therapeutics, Glide Technologies, Crossject, Zogenix, Johnson & Johnson Private Limited, MannKind Corporation, Pancreum, Inc., JDRF, AKRA DERMOJET, Tandem Diabetes Care, Inc., Medtronic among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-